Prevention of DMBA-induced mammary gland tumors in mice by a dual-function inhibitor of JAK3 and EGF receptor tyrosine kinases-Reference-Cited by-同舟云学术

Prevention of DMBA-induced mammary gland tumors in mice by a dual-function inhibitor of JAK3 and EGF receptor tyrosine kinases

Published:2020-03-02 Issue:4 Volume:24 Page:379-387
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Sahin Kazim¹,Yabas Mehmet²,Orhan Cemal¹,Tuzcu Mehmet³,Sahin Taha K.⁴,Ozercan Ibrahim H.⁵,Qazi Sanjive⁶⁷,Uckun Fatih M.⁶⁷

Affiliation:

1. Faculty of Veterinary Medicine, Firat University, Elazig, Turkey

2. Department of Genetics and Bioengineering, Trakya University, Edirne, Turkey

3. Department of Biology, Faculty of Science, Firat University, Elazig, Turkey

4. Department of Internal Medicine, University of Hacettepe School of Medicine, Ankara, Turkey

5. Department of Pathology, Faculty of Medicine, Firat University, Elazig, Turkey

6. Division of Hematology-Oncology, Department of Pediatrics and Developmental Therapeutics Program, Norris Comprehensive Cancer Center, University of Southern California Keck School of Medicine (USC KSOM), Los Angeles, CA, USA

7. Department of Immuno-Oncology, Ares Pharmaceuticals, St. Paul, MN, USA

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2020.1737014

Reference35 articles.

1. Breast cancer

2. Cancer statistics, 2019

3. Global Cancer Statistics, 2002

4. Therapeutic options for metastatic breast cancer

5. Systemic Therapy of Advanced/Metastatic Breast Cancer - Current Evidence and Future Concepts

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic and Local Strategies for Primary Prevention of Breast Cancer;Cancers;2024-01-05

2. ERBB1/EGFR and JAK3 Tyrosine Kinases as Potential Therapeutic Targets in High-Risk Multiple Myeloma;Onco;2022-10-14

3. N‐(be nzylidene)‐2‐((2‐hydroxynaphthalen‐1‐yl)diazenyl)benzohydrazides (1‐2) (NCHDH and NTHDH) attenuate DMBA‐induced breast cancer via Nrf2/NF‐κB/apoptosis signaling;Fundamental & Clinical Pharmacology;2022-03-18